top of page
Interlinked AB
Quality policy Interlinked AB

Quality policy

Interlinked AB is a medical device company with a focus on need-based product development through to commercialisation in accordance with Interlinked’s QMS and applicable regulatory requirements.

 

Interlinked provides breakaway connectors to be used as value enhancing components for medical tubes reducing catheter dislodgement.

ReLink platform

ReLink / LinkUS in action

ReLink is a patented breakaway connector, designed to prevent mechanical complications such as dislodgement, thereby providing increased safety for patients and nurses. It comprises a weak link concept to reduce IV catheter dislodgement in combination with self-sealable valves to prevent spill of IV fluids, medicine, and blood.

ReLink advantages

IV infusions

Nephrostomy drainage

Veterinary IV infusions

dreamstime_xxl_59929888-lower mb.jpg
  • 73% reduction in dislodgement frequency, in a recent EU clinical

       trial (1)​

  • Protects nurses from being exposed to blood & hazardous drug spill

  • Supports accurate drug delivery

  • Helps reduce plastic waste

shutterstock_159603626_lower mb.jpg
  • Minimises risks of catheter dislodgement

  • Minimises expensive replacement

  • Reduces spillage of bodily fluids and risk of exposure and contamination

  • Easily reconnectable, saving nursing time.

dreamstime_xxl_214526885_lower mb.jpg
  • Minimises risks of IV-catheter dislodgement

  • Reduces patient injuries and risk of infections

  • Protects nurses from being exposed to blood & hazardous drug spil

References:
1. Data from the first clinical trial at Uppsala University Hospital, Sweden

ReLink / LinkUS
ReLink / LinkUS feature
ReLink / LinkUS feature
ReLink / LinkUS feature

ReLink features

Breakaway connector

A non-invasive method to reduce
IV catheter dislodgement

Self-sealing valves

The two halves are equipped with self-sealing valves 

Reconnectable

The two halves reconnect to
rapidly resume therapy

Research support

European Union's Horizon

The project has received funding from the European Union's Horizon 2020 research and innovation programme under EIC Accelerator grant, Fast Track to Innovation grant and from the Eurostars-2 Joint Programme with co-funding from the European Union's Horizon 2020 research and innovation programme

eithealth
vinnova

Sustainability

Our innovation not only addresses healthcare and patient safety, but also the wider concerns of European and global importance as outlined in the 2030 agenda for sustainable development.

UN Goals that ReLink / LinkUS fulfills
Goal 3: Good health and well-being 

ReLink is a solution that disrupts the state-of-the-art of IV therapy. The elderly patients, psychiatric patients, as well as paediatric patients will particularly benefit from the improvements that ReLink offers.

UN Goals that ReLink / LinkUS fulfills
Goal 6: Clean water and sanitation

ReLink aids in curbing hazardous chemical pollution, lowering medication wastage, and promoting affordable healthcare solutions, thus addressing global challenges and enhancing safety.

UN Goals that ReLink / LinkUS fulfills
Goal 8: Decent work and economic growth

ReLink enhances global healthcare by saving time and costs, preventing spills, ensuring safety, and creating a positive working environment for healthcare professionals, while being adaptable for home care.

UN Goals that ReLink / LinkUS fulfills
Goal 12: Responsible consumption and production

ReLink will align towards improper waste handling, not only for medicine and chemicals, but also by saving plastic waste annually in Europe and USA.

bottom of page